Vaithianathan Palaniappan
Technik-/Wissenschafts-/F&E-Leiter bei Flagship Pioneering
Aktive Positionen von Vaithianathan Palaniappan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 | - |
Karriereverlauf von Vaithianathan Palaniappan
Ehemalige bekannte Positionen von Vaithianathan Palaniappan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 | 02.11.2021 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2018 | 02.05.2020 |
| International Consortium for Innovation & Quality | Direktor/Vorstandsmitglied | 01.01.2017 | 02.05.2020 |
| Vorsitzender | 01.01.2016 | - | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01.01.2012 | 02.01.2018 |
Ausbildung von Vaithianathan Palaniappan
| Indian Institute of Technology Kanpur | Doctorate Degree |
| Annamalai University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Indien | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
| International Consortium for Innovation & Quality | |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
